Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “Akebia Therapeutics, Inc.”

28 pharma patents match "Akebia Therapeutics, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 28
Index total 30,257
Page 2 / 2

Quick answer

This filtered view shows 28 pharmaceutical patents matching "Akebia Therapeutics, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

28 results for “Akebia Therapeutics, Inc.” · 30,257 patents in full index Clear search

  1. US 8598210

    Prolyl hydroxylase inhibitors and methods of use

    Akebia Therapeutics, Inc. · Granted Dec 3, 2013 · Expires Nov 28, 2033

    granted

  2. US 8343952

    Prolyl hydroxylase inhibitors and methods of use

    Akebia Therapeutics, Inc. · Granted Jan 1, 2013 · Expires Dec 27, 2032

    granted

  3. US 8323671

    Prolyl hydroxylase inhibitors and methods of use

    Akebia Therapeutics, Inc. · Granted Dec 4, 2012 · Expires Nov 29, 2032

    granted

  4. US 8133894

    N-benzyl-4-methyleneamino-3-hydroxy-2-pyridones

    Akebia Therapeutics, Inc. · Granted Mar 13, 2012 · Expires Mar 8, 2032

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.